ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.58M	-
Other	Edwards Larry Todd	150.2K	$3.97M	-
Other	Matsuda Masaru	127.6K	$3.37M	-
Other	Burnett Patrick	120.2K	$3.18M	-
CFO	Vairavan Latha	86.0K	$2.27M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 2, 2025	Welgus Howard G.61	-	Sale+OE	10,000	$15.64	$156,383.00	-9.1%	+98.2%	-
Aug 21, 2025	Burnett Patrick	See Remarks	Sell	4,188	$15.82	$66,249.62	-1.9%	+76.6%	-
Aug 8, 2025	Burnett Patrick	See Remarks	Sell	3,847	$14.03	$53,988.41	-3.4%	+69.9%	-
Aug 4, 2025	Watanabe Todd65	See Remarks	Sell	11,547	$14.33	$165,429.25	-1.3%	+70.5%	-
Aug 4, 2025	Burnett Patrick	See Remarks	Sell	2,622	$14.33	$37,564.35	-2.3%	+70.5%	-
Aug 4, 2025	Vairavan Latha	SVP Chief Financial Officer	Sell	89	$14.33	$1,275.07	-0.1%	+70.5%	-
Aug 4, 2025	Matsuda Masaru51	See Remarks	Sell	6,330	$14.33	$90,687.38	-3.1%	+70.5%	-
Aug 1, 2025	Welgus Howard G.61	-	Sale+OE	10,000	$14.30	$142,982.00	-4.8%	+74.4%	-
Jul 14, 2025	Burnett Patrick	See Remarks	Sale+OE	28,750	$15.05	$432,700.15	-11.1%	+30.3%	-
Jul 1, 2025	Welgus Howard G.61	-	Sell	9,208	$13.84	$127,430.43	-8.4%	+35.4%	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC